Delivery Order SPE2DB20D2014-SPE2DB25FC57G
- Not listed
- The Defense Logistics Agency awarded a $5,369.70 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on September 15, 2025, with completion expected by September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract reflects AmerisourceBergen's role as a critical federal vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,022.80 to supply Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,260.50 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order fulfillment. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a completion date of June 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,767.04 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,034.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 10, 2025, with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens, valued at $1,415.40. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under DLA's existing contract vehicle. The order is scheduled for completion by July 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $4,331.62 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract has a firm fixed price structure and is scheduled for completion by June 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC57GDelivery Order
The Defense Logistics Agency awarded a $6,703.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a single delivery order for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a primary supplier through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 7/28/25 |